Current issue
Journal content
Articles in press
Archive
About the Journal
About the Polish Annals of Medicine
Editorial Board
Abstracting & indexing
Open Access policy
Charges
Affiliated institutions
Contact
Instructions
Peer review process
Guide for authors
Publication ethics
Ethics and Patient Consent
User License
Usage of third party materials
Disclaimer
Statement on Artificial Intelligence
Reviewers
Guide for reviewers
Review Form
RESEARCH PAPER
Evaluation of the impact of individual and environmental factors on the prognosis of women with vulvar cancer
1
Department of Obstetrics and Gynecology Nursing, Medical University of Gdansk, Gdansk, Poland INVICTA Fertility and Reproductive Center, Gdansk, Poland
2
Department of Gynecology, Obstetrics and Gynecological Oncology, Provincial Specialist Hospital in Olsztyn, Poland
Submission date: 2013-06-17
Acceptance date: 2013-09-12
Online publication date: 2013-09-17
Publication date: 2020-04-08
Corresponding author
Janina Lipińska
Department of Gynecology, Gynecological Endocrinology, Gynecological Oncology and Obstetrics, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, ul. Żołnierska 18, 10-516 Olsztyn, Poland. Tel.: +4889 538 64 83.
Department of Gynecology, Gynecological Endocrinology, Gynecological Oncology and Obstetrics, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, ul. Żołnierska 18, 10-516 Olsztyn, Poland. Tel.: +4889 538 64 83.
Pol. Ann. Med. 2013;20(2):110-116
KEYWORDS
ABSTRACT
Introduction:
Vulvar cancer is a rare type of cancer. In Poland in 2010 there were 491 cases of vulvar cancer. Prognostic factors that may influence the course of the disease and results of treatment can be divided into factors associated with tumor, individual factors of the patient (age, socioeconomic status, co-morbidities, body weight, motivation to comply) and environmental factors.
Aim:
The purpose of this research was to evaluate the impact of individual and environmental factors on the prognosis of women with vulvar cancer, regardless of the clinical stage.
Material and methods:
The study group consisted of 48 patients with invasive squamous cell carcinoma of the vulva treated surgically in the Department of Gynecological Oncology in Olsztyn in 1995–2008. Analysis included age, place of living, occupational status, marital status, obstetric history, co-morbidities, body weight, and healing of post-operative wound. Univariate analysis of the effect of these factors on survival and recurrence rates was performed.
Results and discussion:
Univariate analysis showed a relationship between impaired post-operative wound healing and recurrence rate (p < .05). Wound healing complicated by abscess formation occurred most frequently in patients with T2 stage tumor and did not correlate with lymph node involvement. No effect of age, body weight, age at menarche and age at menopause, and number of births on the presence or absence of recurrence was observed (p < .05).
Conclusions:
In patients with post-operative wound healing complications due to infection statistically significant worse survival rates have been observed. Vulvar cancer was repeatedly diagnosed 22 years after menopause, in its advanced stages (according to FIGO 1988). No correlation between survival rate and demographic factors, environmental factors, gynecological and obstetric history and co-morbidities was demonstrated. Difference between
Vulvar cancer is a rare type of cancer. In Poland in 2010 there were 491 cases of vulvar cancer. Prognostic factors that may influence the course of the disease and results of treatment can be divided into factors associated with tumor, individual factors of the patient (age, socioeconomic status, co-morbidities, body weight, motivation to comply) and environmental factors.
Aim:
The purpose of this research was to evaluate the impact of individual and environmental factors on the prognosis of women with vulvar cancer, regardless of the clinical stage.
Material and methods:
The study group consisted of 48 patients with invasive squamous cell carcinoma of the vulva treated surgically in the Department of Gynecological Oncology in Olsztyn in 1995–2008. Analysis included age, place of living, occupational status, marital status, obstetric history, co-morbidities, body weight, and healing of post-operative wound. Univariate analysis of the effect of these factors on survival and recurrence rates was performed.
Results and discussion:
Univariate analysis showed a relationship between impaired post-operative wound healing and recurrence rate (p < .05). Wound healing complicated by abscess formation occurred most frequently in patients with T2 stage tumor and did not correlate with lymph node involvement. No effect of age, body weight, age at menarche and age at menopause, and number of births on the presence or absence of recurrence was observed (p < .05).
Conclusions:
In patients with post-operative wound healing complications due to infection statistically significant worse survival rates have been observed. Vulvar cancer was repeatedly diagnosed 22 years after menopause, in its advanced stages (according to FIGO 1988). No correlation between survival rate and demographic factors, environmental factors, gynecological and obstetric history and co-morbidities was demonstrated. Difference between
CONFLICT OF INTEREST
None declared.
REFERENCES (22)
1.
Barnes EA, Thomas G. Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol. 2006;16(3):168–176.
2.
Blecharz P, Karolewski K, Bieda T, Klimek M, Pudelek J, Kojs E, et al. Prognostic factors in patients with carcinoma of the vulva – our own experience and literature review. Eur J Gynaecol Oncol. 2008;29(3):260–263.
3.
Brinton LA, Nasca PC, Mallin K, Baptiste MS, Wilbanks GD, Richard RM. Case-control study of cancer of the vulva. Obstet Gynecol. 1990;75(5):859–866.
4.
Centrum Onkologii Warszawa. Krajowy Rejestr Nowotworów. Available from: 〈epid.coi.waw.pl/krn〉.
5.
Elg SA, Carson LF, Brooker DC, Carter JR, Twiggs LB. Infectious morbidity after radical vulvectomy. Infect Dis Obstet Gynecol. 1994;2(3):130–135.
6.
Ghebre RG, Posthuma R, Vogel RI, Geller MA, Carson LF. Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer. Gynecol Oncol. 2011;121(3):595–599. http://dx.doi.org/10.1016/j.yg....
7.
Green Th. Carcinoma of the vulva. A reassessment. Obstet Gynecol. 1978;52(4):462–469.
8.
Konefka T. Ocena wyników leczenia chorych na raka płaskonabłonkowego sromu z uwzględnieniem możliwości zastosowania zabiegów oszczędzających [rozprawa doktorska] [Evaluation of treatment results of patients with squamous cell carcinoma of the vulva including possible use of conservative treatment] [doctoral dissertation]. Gdańsk; 1997 [in Polish].
9.
Kumar S, Shah JP, Bryant CS, Imudia AN, Morris RT, Malone JM. Comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol. 2009;200(5):e52–e55. http://dx.doi.org/10.1016/j.aj....
10.
Leminen A, Forss M, Paavonen J. Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies. Eur J Obstet Gynecol Reprod Biol. 2000;93(2):193–197.
11.
Oonk MH, Hullu JA, Hollema H, Mourits MJ, Pras E, Wymenga AN, et al. The value of routine follow-up in patients treated for carcinoma of the vulva. Cancer. 2003;98(12):2624–2629.
12.
Parazzini F, Moroni S, Negri E, La Vecchia C, Dal Pino D, Cavalleri E. Selected food intake and risk of vulvar cancer. Cancer. 1995;76(11):2291–2296.
13.
Parham GP, Hicks ML. Gynecologic cancer among the socioeconomically disadvantaged. Cancer Suppl. 1995;76(suppl 10):2176–2180.
14.
Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, Michalas S. Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol. 2000;78(3 Pt 1):346–351.
15.
Rutledge FN, Mitchell MF, Munsell MF, Atkinson EN, Bass S, McGuffee V, et al. Prognostic indicators for invasive carcinoma of the vulva. Gynecol Oncol. 1991;42(3):239–244.
16.
Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, et al. Incidence of in situ and invasive vulvar cancer in situ in the US, 1998–2003. Cancer. 2008;113(suppl 10):2865–2872. http://dx.doi.org/10.1002/cncr....
17.
Sherman KJ, Daling JR, McKnight B, Chu J. Hormonal factors in vulvar cancer. A case-control study. J Reprod Med. 1994;39(11):857–861.
18.
Sznurkowski JJ, Emerich J. Characteristic features of recurrences of squamous cell carcinoma of the vulva. Ginekol Pol. 2010;81(1):12–19.
19.
Tyring SK. Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment. Am J Obstet Gynecol. 2003;189(suppl 3):S17–S23.
20.
Urban A, Wala D, Miszczyk L, Suwiński R. Ocena wyników leczenia złośliwych nowotworów sromu w materiale operacyjnym chorych Kliniki Ginekologii i Położnictwa w Bytomiu [Evaluation of treatment results of vulvar cancer in posto-perative material of patients of the Clinic of Obstetrics and Gynecology in Bytom]. Współcz Onkol. 2002;6(7):458–463 [in Polish].
21.
Vlastos AT, Usel M, Beffa V, Petignat P, Nayround-Caspar I, Bouchardy C, et al. Treatment patterns of vulvar cancer in the elderly. Surg Oncol. 2004;13(4):187–191.
22.
Zwierko M, Wronkowski Z. Epidemiologia [Epidemology]. In: Markowska J, Mądry R, eds. Zarys ginekologii onkologicznej [Gynecological oncology], Vol. 1. Poznań: Temida; 2012:39.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
